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Background: Nuclear factor-kappaB (NF-kB), a stress-responsive transcription factor, has been implicated in various cardiovascular pathologies. 
Although NF-kB is necessary for late preconditioning, its summative role in myocardial ischemia/reperfusion (I/R) injury remains unclear.
Methods: Using mice with cardiac-specific inhibition of NF-kB activation via transgenic overexpression of a mutant IkBa protein, we examined 
the role of NF-kB in myocyte death in a mouse model of I/R injury. Considering the nonspecific actions of various pharmacological inhibitors of 
NF-kB, this genetic model offers the advantage of specifically ablating NF-kB activation in myocytes. Age-matched male wild-type (WT, C57BL/6, 
n=7), nontransgenic littermates (NTg, n=6) and IkBa transgenic (IkBa Tg, n=6) mice underwent a 30-min coronary occlusion followed by 24 h of 
reperfusion. Mice were sacrificed and infarct size was determined by TTC staining.
Results: The infarct size was similar in WT controls and NTg mice (Figure), indicating no untoward impact in NTg hearts. However, the infarct 
size was significantly smaller in IkBa Tg mice compared with both WT and NTg groups (Figure), indicating that myocardial NF-kB signaling plays a 
detrimental role during acute I/R injury.
Conclusions: We conclude that NF-kB inhibition protects against acute myocardial I/R injury. These findings are relevant toward developing novel 
therapeutic strategies against myocardial infarction via modulation of NF-kB signaling in the heart.
 
